Loading...
Capecitabine — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Capecitabine
2025-Q4
Comprehensive analysis of India’s capecitabine export trade — suppliers, buyers, prices, routes, and every shipment record.
184
Shipments
$1.25M
Trade Value
59
Suppliers
38
Buyers
46
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/capecitabine
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s capecitabine trade — 2025-Q4
KEY TAKEAWAY
Capecitabine 2025-Q4 exports total $1.2M across 46 countries, with INTAS PHARMACEUTICALS LTD commanding 21.9% market share.
TOTAL SHIPMENTS
184
2025-Q4
EXPORT VALUE
$1.2M
FOB USD
TOTAL QUANTITY
4.4M
units shipped
INDIAN SUPPLIERS
59
unique exporters
GLOBAL BUYERS
38
unique importers
DESTINATIONS
46
countries
MEDIAN UNIT PRICE
$0.520
per unit
TOP-5 SHARE
77.8%
of total USD
BRANDED SHARE
57.6%
106 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
INTAS PHARMACEUTICALS LTD is India's #1 Capecitabine exporter with $273.9K (21.9% market share).→ §5, Indian Supplier Rankings
2
Capecitabine reached 46 countries, with South Africa as the top destination ($365.1K).→ §4, Global Destination Map
3
Market concentration is low (HHI: 1459) — top 10 suppliers control 91.8% of exports.→ §5, Indian Supplier Rankings
4
92.1% of buyers (35 of 38) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (73.3%) across 2 dosage forms.→ §7, Price Benchmarks
6
45 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 INTAS PHARMACEUTICALS LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian capecitabine exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Capecitabine report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial capecitabine trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian capecitabine suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Capecitabine India trade report
Product scope
Capecitabine
All variants merged — branded and generic formulations of capecitabine
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
184
Every commercial capecitabine trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $77.6K, Nov $930.4K, Dec $241.8K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$77.6K
Oct USD
9 shipments
2
$930.4K
Nov USD
+1099.7% MoM
3
$241.8K
Dec USD
-74.0% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 1099.7% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $78K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $1.2M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $853K rise in Nov, $689K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $78K | 9 shipments |
| Nov | $930K | 64 shipments |
| Dec | $242K | 111 shipments |
| Q4 Total | $1.2M | 184 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: South Africa held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: SUN PHARMACEUTICAL INDUSTRIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import capecitabine from India, how much they buy, and who supplies each market
KEY TAKEAWAY
South Africa absorbs 29.2% of India’s 2025-Q4 capecitabine trade ($365.1K). Beyond the top 10 destinations, 45 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 17 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 45 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much capecitabine India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$465K
37.2% of trade
15 countries · 70 shipments
Americas
$348K
27.8% of trade
13 countries · 52 shipments
Africa
$437K
34.9% of trade
17 countries · 61 shipments
Oceania
$954
0.1% of trade
1 countries · 1 shipments
Fig 4.1 South Africa is the #1 corridor ($365K) — 30 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian capecitabine it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | South Africa | $365K | 11 | CIPLA LTD | $234K | INTAS PHARMACEUTICALS LTD | $131K | — | — |
| 2 | Hong Kong | $143K | 6 | INTAS PHARMACEUTICALS LTD | $143K | — | — | — | — |
| 3 | United States | $118K | 4 | ALKEM LABORATORIES LTD | $118K | — | — | — | — |
| 4 | Brazil | $107K | 1 | SUN PHARMACEUTICAL INDUSTRIES LTD | $107K | — | — | — | — |
| 5 | Philippines | $83K | 21 | BETA DRUGS LTD | $83K | — | — | — | — |
| 6 | Israel | $83K | 2 | SUN PHARMACEUTICAL INDUSTRIES LTD | $83K | — | — | — | — |
| 7 | Canada | $74K | 2 | SUN PHARMACEUTICAL INDUSTRIES LTD | $73K | SANDOZ PVT LTD | $504 | — | — |
| 8 | Cambodia | $67K | 4 | FLORENCIA HEALTHCARE | $65K | BRUCK PHARMA PVT LTD | $1K | VANDAN HEALTHCARE | $507 |
| 9 | Afghanistan | $41K | 7 | RESCUERS LIFE SCIENCES LTD | $37K | KWALITY PHARMACEUTICALS LTD | $4K | MEDMATRIX ASSOCIATES | $153 |
| 10 | Uruguay | $25K | 1 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | $25K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 37.2% of USD — but South Africa is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
29.2%
#1 country share
South Africa alone
65.3%
Top 5 share
5 of 46 countries
94.8%
Top 15 share
Long tail of 31 countries = 5.2%
HHI 1324
Destination HHI
Competitive spread
46
Countries served
Global pharma reach from India
17
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
59 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
INTAS PHARMACEUTICALS LTD ($273.9K, 21.9% share) and SUN PHARMACEUTICAL INDUSTRIES LTD ($263.2K) together control 43.0% of India’s 2025-Q4 capecitabine trade. The top 5 suppliers hold 77.8%. 59 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian capecitabine suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 INTAS PHARMACEUTICALS LTD leads by $11K over SUN PHARMACEUTICAL INDUSTRIES LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: AMRS HEALTHCARE PVT is #18 by value but #1 by volume.
Fig 5.2 AMRS HEALTHCARE PVT LTD also leads by shipment count (33) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: AMRS HEALTHCARE PVT moves from #1 by volume to #18 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 59 capecitabine suppliers split into strategic segments
KEY TAKEAWAY
15 suppliers (25%) generate 95.5% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 INTAS PHARMACEUTICALS LTD and SUN PHARMACEUTICAL INDUSTRIES LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 95.5% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LTD | 1 | 2 | $274K |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LTD | 1 | 3 | $263K |
| 3 | CIPLA LTD | 1 | 1 | $234K |
| 4 | ALKEM LABORATORIES LTD | 1 | 1 | $118K |
| 5 | BETA DRUGS LTD | 1 | 1 | $83K |
| 6 | FLORENCIA HEALTHCARE | 1 | 1 | $65K |
| 7 | RESCUERS LIFE SCIENCES LTD | 1 | 1 | $37K |
| 8 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | 1 | 2 | $31K |
| 9 | RELIANCE LIFE SCIENCES PVT LTD | 1 | 2 | $26K |
| 10 | AASHVI PHARMACEUTICALS PVT LTD | 1 | 1 | $17K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the capecitabine manufacturing hubs
KEY TAKEAWAY
Mumbai and Ahmedabad together account for $612K of India’s 2025-Q4 capecitabine trade.
Fig 5.5 Mumbai (15 exporters, $309K) and Ahmedabad (7 exporters, $303K) are India’s capecitabine capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
77.8%
Top 5 share
5 of 59 suppliers
91.8%
Top 10 share
10 of 59 suppliers
95.5%
Top 25% share
15 suppliers = 95% USD
HHI 1459
Supplier HHI
Competitive
59
Total suppliers
shipped Capecitabine in 2025-Q4
20+ cities
Indian hubs
Mumbai and Ahmedabad lead
§5.2 Coming next: 3 exporter deep-dive profiles
Each of the top 3 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | INTAS PHARMACEUTICALS LTD | $274K |
| #2 | BRUCK PHARMA PVT LTD | $3K |
| #3 | MDS ENTERPRISES | $3K |
#1
EXPORTER PROFILE #1 OF 3
INTAS PHARMACEUTICALS LTD
Ahmedabad · India’s #1 capecitabine supplier by USD · 2025-Q4
2025-Q4 USD
$274K
21.9% market share
SHIPMENTS
11
avg $25K/ship
COUNTRIES
2
destination markets
BUYERS
1
unique importers
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Hong Kong is the #1 market at $143K (52% of trade), followed by South Africa at $131K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Hong Kong | $143K | 6 | 52.0% |
| 2 | South Africa | $131K | 5 | 48.0% |
MONTHLY TREND
Nov peaked at $272K. Oct was the weakest at $0.
PRODUCT MIX
Unknown dominates at 99% of trade. Tablet (0.9%) and others are secondary formulations.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | South Africa | $274K | N/A |
#1
EXPORTER PROFILE #1 OF 3 — TRADE FLOW MAP
INTAS PHARMACEUTICALS LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 Hong Kong absorbs $143K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#22
EXPORTER PROFILE #2 OF 3
BRUCK PHARMA PVT LTD
Nani · India’s #22 capecitabine supplier by USD · 2025-Q4
2025-Q4 USD
$3K
0.2% market share
SHIPMENTS
5
avg $619/ship
COUNTRIES
4
destination markets
BUYERS
1
unique importers
BRANDED
80%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Cambodia is the #1 market at $1K (46% of trade), followed by Papua New Guinea at $954. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Cambodia | $1K | 2 | 45.6% |
| 2 | Papua New Guinea | $954 | 1 | 30.8% |
| 3 | Burundi | $729 | 1 | 23.6% |
| 4 | Cote d'Ivoire | $0 | 1 | 0.0% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $2K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Cambodia | $3K | N/A |
#22
EXPORTER PROFILE #2 OF 3 — TRADE FLOW MAP
BRUCK PHARMA PVT LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P2.3 Cambodia absorbs $1K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 1 importers per destination.
#24
EXPORTER PROFILE #3 OF 3
MDS ENTERPRISES
Mumbai · India’s #24 capecitabine supplier by USD · 2025-Q4
2025-Q4 USD
$3K
0.2% market share
SHIPMENTS
6
avg $446/ship
COUNTRIES
2
destination markets
BUYERS
1
unique importers
BRANDED
100%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Ghana is the #1 market at $3K (99% of trade), followed by United Arab Emirates at $19. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Ghana | $3K | 3 | 99.3% |
| 2 | United Arab Emirates | $19 | 3 | 0.7% |
MONTHLY TREND
Nov peaked at $2K. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Ghana | $3K | N/A |
#24
EXPORTER PROFILE #3 OF 3 — TRADE FLOW MAP
MDS ENTERPRISES — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 Ghana absorbs $3K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
38 importers across 46 countries — who is buying Indian capecitabine and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 47.9% of total USD. 92% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian capecitabine. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 MEDPRO PHARMACEUTICA PTY LTD is the #1 importer at $144K (11.5%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
92%
Single-source
35 buyers rely on exactly 1 Indian supplier
3%
Dual-source
1 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
5%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source capecitabine from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Nepal 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PHARMACHEM PVT LTD | RELIANCE LIFE SCIENC… | $15K | $2.427 | Tablet |
| AM BIOTECH PVT LTD | BDR PHARMACEUTICALS … | $6K | $2.161 | Tablet |
| NIKHIL PHARMA PVT LTD | UNITED BIOTECH PVT LTD | $975.288 | $6.502 | Tablet |
| BISTRA PHARMA LINK PVT… | KHANDELWAL LABORATOR… | $40.287 | $0.201 | Tablet |
Ghana 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| DESH CHEMISTS LTD | PHARMEDA HEALTHCARE … | $6K | $1.848 | Tablet |
| PHILTA PHARMACY AND HE… | LIFENEST PHARMA LLP | $3K | $2.116 | Capsule |
| THE MANAGER SA | GRAMEEN PHARMA LLP | $4.700 | $0.016 | Tablet |
Kenya 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| FOR THE ORDER OF | 3S CORP | $1K | $1.391 | Tablet |
| SALAMA PHARMACUTICALS … | M T MADON EXPORTS | $670.724 | $1.341 | Tablet |
| ABU AHMED | AMARI TRADE ALLIANCE… | $248.527 | $1.243 | Tablet |
Philippines 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| 2 MG INC | BETA DRUGS LTD | $83K | $16.572 | Tablet |
| 2MG INC | BETA DRUGS LTD | $583.588 | $0.192 | Tablet |
Canada 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| M/S.SUN PHARMA CANADA … | SUN PHARMACEUTICAL I… | $73K | $0.617 | Tablet |
| SANDOZ CANADA INC | SANDOZ PVT LTD | $504.482 | $0.270 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | MEDPRO PHARMACEUTICA… | South Africa | $144K | $36K | Premium |
| 2 | SUN FARMACEUTICA DO … | Brazil | $107K | $107K | Premium |
| 3 | 2 MG INC | Philippines | $83K | $8K | Budget |
| 4 | M/S.SUN PHARMA CANAD… | Canada | $73K | $73K | Premium |
| 5 | ASCEND LABORATORIES … | United States | $72K | $24K | Mid |
| 6 | ETEMED MOSLEH LTD | Afghanistan | $37K | $12K | Budget |
| 7 | NPINSA | Uruguay | $25K | $25K | Mid |
| 8 | PHARMACHEM PVT LTD | Nepal | $15K | $15K | Budget |
| 9 | BIOTENG S.A | Paraguay | $6K | $6K | Budget |
| 10 | AM BIOTECH PVT LTD | Nepal | $6K | $2K | Budget |
| 11 | DESH CHEMISTS LTD | Ghana | $6K | $6K | Budget |
| 12 | CENTRAIMED | Equatorial Guinea | $5K | $5K | Budget |
| 13 | TRUST ANESTHETIC LTD | Afghanistan | $4K | $1K | Budget |
| 14 | PHILTA PHARMACY AND … | Ghana | $3K | $3K | Budget |
| 15 | /FOR THE ORDER OF | Zimbabwe | $3K | $3K | Budget |
| 16 | BRYDEN A S & SONS AN… | Antigua and Barbuda | $2K | $2K | Budget |
| 17 | HAZMAC BAHAMAS | Bahamas | $2K | $2K | Budget |
| 18 | DALIAN CHAOHONGSUPPL… | China | $2K | $2K | Budget |
| 19 | HOPITAL CARAMED CLIN… | Haiti | $2K | $2K | Budget |
| 20 | FOR THE ORDER OF | Kenya | $1K | $591.000 | Budget |
| 21 | NIKHIL PHARMA PVT LTD | Nepal | $975.288 | $975.000 | Budget |
| 22 | CAMEROON ONCOLOGY CE… | Cameroon | $700.796 | $701.000 | Budget |
| 23 | SALAMA PHARMACUTICAL… | Kenya | $670.724 | $671.000 | Budget |
| 24 | 2MG INC | Philippines | $583.588 | $58.000 | Budget |
| 25 | SANDOZ CANADA INC | Canada | $504.482 | $504.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 INTAS PHARMACEUTICALS LTD → MEDPRO PHARMACEUTICA PTY LTD is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian capecitabine prices vary by supplier, country and dosage form
KEY TAKEAWAY
Capecitabine prices span 16852× ($0.0018 → $30.71). The coefficient of variation is 1.70. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0018 | Lowest observed unit price |
| P5 | $0.0030 | 5th percentile |
| P25 | $0.019 | 25th percentile (Q1) |
| Median | $0.520 | 50th percentile (Q2) |
| P75 | $2.86 | 75th percentile (Q3) |
| P95 | $16.57 | 95th percentile |
| Max | $30.71 | Highest observed unit price |
| Mean | $3.53 | Arithmetic average |
| CV | 170% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 PIRZE LIFECARE PVT LTD prices at $17.02/unit vs market median $0.520.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. INTAS PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ALKEM LABORATORIES LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. AASHVI PHARMACEUTICALS PVT Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. FLORENCIA HEALTHCARE Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | ASPIRA BIOHEALTH… | Kenya | Tablet | 100 | $3K | $31.16 | Specialty / small-batch |
| Nov 2025 | DOSSMEGT PHARMAC… | Haiti | Tablet | 50 | $2K | $30.71 | Specialty / small-batch |
| Nov 2025 | PHARMEDA HEALTHC… | Togo | Tablet | 20 | $487.04 | $24.35 | Specialty / small-batch |
| Dec 2025 | M CARE | Oman | Tablet | 3 | $70.95 | $23.65 | Specialty / small-batch |
| Dec 2025 | BRUCK PHARMA PVT… | Papua New Guinea | Tablet | 50 | $954.17 | $19.08 | Specialty / small-batch |
| Dec 2025 | MDS ENTERPRISES | Ghana | Tablet | 50 | $875.51 | $17.51 | Specialty / small-batch |
| Dec 2025 | PIRZE LIFECARE P… | Equatorial Guinea | — | 300 | $5K | $17.02 | Specialty / small-batch |
| Nov 2025 | BETA DRUGS LTD | Philippines | Tablet | 371 | $6K | $16.57 | Specialty / small-batch |
| Nov 2025 | BETA DRUGS LTD | Philippines | Tablet | 462 | $8K | $16.57 | Specialty / small-batch |
| Nov 2025 | BETA DRUGS LTD | Philippines | Tablet | 462 | $8K | $16.57 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | BIOZENTA LIFESCI… | Egypt | Tablet | 41K | $74.70 | $0.0018 | Bulk generic tablet |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Tablet | 46K | $137.57 | $0.0030 | Bulk generic tablet |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Tablet | 46K | $136.98 | $0.0030 | Bulk generic tablet |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Tablet | 46K | $136.98 | $0.0030 | Bulk generic tablet |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Tablet | 46K | $136.98 | $0.0030 | Bulk generic tablet |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Tablet | 46K | $136.98 | $0.0030 | Bulk generic tablet |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Tablet | 46K | $136.98 | $0.0030 | Bulk generic tablet |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Tablet | 46K | $136.98 | $0.0030 | Bulk generic tablet |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Tablet | 46K | $136.98 | $0.0030 | Bulk generic tablet |
| Dec 2025 | AMRS HEALTHCARE … | Venezuela | Tablet | 46K | $136.98 | $0.0030 | Bulk generic tablet |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship capecitabine, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Capecitabine leaves India through 11+ ports. The top 5 (DELHI AIR, NHAVA SHEVA SEA (JNPT), AHMEDABAD AIR) handle 98.3% of total USD. AIR moves 90% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 DELHI AIR handles $364K — top 11 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Durban is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 90% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$857K
68.6% of USD · 89.7% of ships
SEA
$305K
24.4% of USD · 8.2% of ships
ICD
$73K
5.9% of USD · 1.6% of ships
ROAD
$15K
1.2% of USD · 0.5% of ships
Fig 8.3 The dominant corridor is DELHI AIR → Air → Asia ($212K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Philippines is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 3507).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Philippines (HHI 10,000) is the most concentrated — Kenya (HHI 3,507) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| MEDPRO PHARMACEUTICA… | South Africa | CIPLA LTD | $144K | 4 | HIGH |
| SUN FARMACEUTICA DO … | Brazil | SUN PHARMACEUTIC… | $107K | 1 | HIGH |
| 2 MG INC | Philippines | BETA DRUGS LTD | $83K | 11 | MEDIUM |
| M/S.SUN PHARMA CANAD… | Canada | SUN PHARMACEUTIC… | $73K | 1 | MEDIUM |
| ASCEND LABORATORIES … | United States | ALKEM LABORATORI… | $72K | 3 | MEDIUM |
| ETEMED MOSLEH LTD | Afghanistan | RESCUERS LIFE SC… | $37K | 3 | MEDIUM |
| NPINSA | Uruguay | BDR PHARMACEUTIC… | $25K | 1 | MEDIUM |
| PHARMACHEM PVT LTD | Nepal | RELIANCE LIFE SC… | $15K | 1 | MEDIUM |
Conclusion: 35 buyers depend on exactly one Indian supplier, representing $596K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Hong Kong | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Brazil | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Israel | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Canada | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Cambodia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Uruguay | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Tanzania | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Tajikistan | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Paraguay | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in South Africa | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Philippines lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter South Africa (2 suppliers) | This Q | HIGH |
| A6 | Enter Hong Kong (1 suppliers) | This Q | MED |
| A8 | Build Hong Kong distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for South Africa tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | South Africa | Africa | 2 | $365K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Hong Kong | Asia | 1 | $143K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | United States | Other | 1 | $118K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Brazil | Other | 1 | $107K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Philippines | Asia | 1 | $83K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Israel | Other | 1 | $83K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Canada | Other | 2 | $74K | -99.3% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Cambodia | Asia | 3 | $67K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 9 | Afghanistan | Asia | 4 | $41K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 10 | Zimbabwe | Africa | 2 | $5K | +663.7% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Uruguay | Other | 1 | $25K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Nepal | Asia | 4 | $22K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 13 | Tanzania | Africa | 2 | $17K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Tajikistan | Asia | 1 | $15K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Paraguay | Other | 1 | $12K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 184 2025-Q4 Capecitabine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/capecitabine
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 184 2025-Q4 capecitabine shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian capecitabine shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
184
across all regions
TOTAL USD
$1.25M
2025-Q4 FOB value
UNITS
4.4M
tablets, capsules, etc.
SUPPLIERS
59
Indian exporters
BUYERS
38
global importers
COUNTRIES
46
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $437K (34.9%), spanning 17 countries.
59 Indian suppliers shipped to 38 buyers across 46 countries — average shipment value $7K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
17 countries · 61 shipments · $437K · 32 Indian suppliers · 16 buyers
SHIPMENTS
61
USD
$437K
COUNTRIES
17
SUPPLIERS
32
BUYERS
16
HHI
3,801
concentrated
Top 17 destination countries in Africa
1
South Africa (83.6%)
$365K
2
Tanzania (3.8%)
$17K
3
Kenya (2.8%)
$12K
4
Ghana (2.6%)
$11K
5
Cameroon (2.6%)
$11K
6
Madagascar (1.9%)
$8K
7
Equatorial Guinea (1.2%)
$5K
8
Zimbabwe (1.1%)
$5K
9
Burundi (0.2%)
$729.00
10
Togo (0.1%)
$487.04
11
DR Congo (0.0%)
$137.93
12
Egypt (0.0%)
$132.79
13
Angola (0.0%)
$15.37
14
Ethiopia (0.0%)
$11.47
15
Burkina Faso (0.0%)
$1.88
16
Cote d'Ivoire (0.0%)
$0.071
17
Lesotho · Lesotho
$0.0000
Top 30 Indian suppliers into Africa
1
CIPLA LTD
$234K
2
INTAS PHARMACEUTICALS LTD
$131K
3
AASHVI PHARMACEUTICALS PVT LTD
$17K
4
NEOPHAR PHARMACEUTICALS PVT LTD
$9K
5
FLORENCIA HEALTHCARE PVT LTD
$8K
6
R.S. SURGIPHARM PVT LTD
$6K
7
PHARMEDA HEALTHCARE PVT LTD
$6K
8
PIRZE LIFECARE PVT LTD
$5K
9
LIFENEST PHARMA LLP
$3K
10
ASPIRA BIOHEALTH LLP
$3K
11
3S PHARMACEUTICALS INDIA PVT LTD
$3K
12
MDS ENTERPRISES
$3K
13
RUTVA MEDICARE
$2K
14
3S CORP
$1K
15
MELON GLOBALCARE
$874.62
16
BRUCK PHARMA PVT LTD
$729.07
17
RMPL PHARMA LLP
$715.55
18
SUDDHASATTWA RAY
$700.80
19
M T MADON EXPORTS
$670.72
20
KLV HEALTHCARE PVT LTD
$630.00
21
RUN MEDWAY
$489.57
22
AMARI TRADE ALLIANCE LLP
$248.53
23
COSMOS PHARMA
$133.62
24
BIOZENTA LIFESCIENCE PVT LTD
$74.70
25
J.A. UNITED EXPORTS PVT LTD
$58.09
26
EXGEN CARE PVT LTD
$15.37
27
S. HIMATLAL HEALTHCARE LLP
$11.47
28
GRAMEEN PHARMA LLP
$4.70
29
EUGIA PHARMA SPECIALITIES LTD
$4.41
30
YOGI CARE PHARMACEUTICAL PVT LTD
$4.31
Top 14 Africa importers
1
MEDPRO PHARMACEUTICA PTY LTD · South Africa
$144K
2
DESH CHEMISTS LTD · Ghana
$6K
3
CENTRAIMED · Equatorial Guinea
$5K
4
PHILTA PHARMACY AND HEALTHCARE · Ghana
$3K
5
/FOR THE ORDER OF · Zimbabwe
$3K
6
FOR THE ORDER OF · Kenya
$1K
7
CAMEROON ONCOLOGY CENTRE IN DOUALA · Cameroon
$700.80
8
SALAMA PHARMACUTICALS LTD · Kenya
$670.72
9
CLYZ PHARMA SARL · Cameroon
$489.57
10
ABU AHMED · Kenya
$248.53
11
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Egypt
$58.09
12
THE MANAGER SA · Ghana
$4.70
13
GENERICS & SPECIALITIES LTD · Tanzania
$4.41
14
LIFELINE PHARMACEUTICALS OF · Lesotho
$0.0000
Top 3 dosage forms
1
Tablet
$299K
2
Unknown
$135K
3
Capsule
$3K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $545.94 | $109.19 |
| Nov | 22 | $385K | $17K |
| Dec | 34 | $52K | $2K |
Shipment register · 61 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CIPLA LTD · 6 shipments · $234K | |||||||||||
| 1 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 82.2K | NOS | $0.516 | $42K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 2 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 86.4K | NOS | $0.520 | $45K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 3 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 86.4K | NOS | $0.520 | $45K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 4 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 86.4K | NOS | $0.520 | $45K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 5 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 86.4K | NOS | $0.520 | $45K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 6 | Dec 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 59.9K | NOS | $0.196 | $12K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| SUPPLIER #2 — INTAS PHARMACEUTICALS LTD · 5 shipments · $131K | |||||||||||
| 7 | Nov 2025 | UNLISTED BUYER | South Africa | 112.3K | TBS | $0.283 | $32K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR | |
| 8 | Nov 2025 | UNLISTED BUYER | South Africa | 115.3K | TBS | $0.282 | $33K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR | |
| 9 | Nov 2025 | UNLISTED BUYER | South Africa | 113.6K | TBS | $0.282 | $32K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR | |
| 10 | Nov 2025 | UNLISTED BUYER | South Africa | 115.4K | TBS | $0.282 | $33K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR | |
| 11 | Dec 2025 | UNLISTED BUYER | South Africa | Tablet | 55.2K | TBS | $0.043 | $2K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR |
| SUPPLIER #3 — AASHVI PHARMACEUTICALS PVT LTD · 2 shipments · $17K | |||||||||||
| 12 | Nov 2025 | UNLISTED BUYER | Tanzania | Tablet | 3.0K | NOS | $2.80 | $8K | DELHI AIR | DAR ES SALAM (DARESS | AIR |
| 13 | Nov 2025 | UNLISTED BUYER | Tanzania | Tablet | 3.0K | NOS | $2.80 | $8K | DELHI AIR | DAR ES SALAM (DARESS | AIR |
| SUPPLIER #4 — NEOPHAR PHARMACEUTICALS PVT LTD · 2 shipments · $9K | |||||||||||
| 14 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 1.0K | NOS | $2.85 | $3K | DELHI AIR | DOUALA | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 2.0K | NOS | $2.85 | $6K | DELHI AIR | DOUALA | AIR |
| SUPPLIER #5 — FLORENCIA HEALTHCARE PVT LTD · 3 shipments · $8K | |||||||||||
| 16 | Dec 2025 | UNLISTED BUYER | Madagascar | Tablet | 380 | NOS | $7.51 | $3K | DELHI AIR | ANTANANARIVO | AIR |
| 17 | Dec 2025 | UNLISTED BUYER | Madagascar | Tablet | 380 | NOS | $7.12 | $3K | DELHI AIR | ANTANANARIVO | AIR |
| 18 | Dec 2025 | UNLISTED BUYER | Madagascar | Tablet | 380 | NOS | $7.50 | $3K | DELHI AIR | ANTANANARIVO | AIR |
| SUPPLIER #6 — R.S. SURGIPHARM PVT LTD · 2 shipments · $6K | |||||||||||
| 19 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 900 | NOS | $1.79 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 20 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 2.4K | PCS | $2.00 | $5K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #7 — PHARMEDA HEALTHCARE PVT LTD · 2 shipments · $6K | |||||||||||
| 21 | Nov 2025 | UNLISTED BUYER | Togo | Tablet | 20 | PCS | $24.35 | $487.04 | DELHI AIR | LOME | AIR |
| 22 | Nov 2025 | DESH CHEMISTS LTD | Ghana | Tablet | 3.0K | NOS | $1.85 | $6K | DELHI AIR | ACCRA | AIR |
| SUPPLIER #8 — PIRZE LIFECARE PVT LTD · 1 shipments · $5K | |||||||||||
| 23 | Dec 2025 | CENTRAIMED | Equatorial Guinea | 300 | NOS | $17.02 | $5K | AHMEDABAD AIR | MALABO | AIR | |
| SUPPLIER #9 — LIFENEST PHARMA LLP · 1 shipments · $3K | |||||||||||
| 24 | Nov 2025 | PHILTA PHARMACY AND HEALTHCARE | Ghana | Capsule | 1.5K | NOS | $2.12 | $3K | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #10 — ASPIRA BIOHEALTH LLP · 1 shipments · $3K | |||||||||||
| 25 | Nov 2025 | UNLISTED BUYER | Kenya | Tablet | 100 | NOS | $31.16 | $3K | CHENNAI AIR | NAIROBI | AIR |
| SUPPLIER #11 — 3S PHARMACEUTICALS INDIA PVT LTD · 1 shipments · $3K | |||||||||||
| 26 | Dec 2025 | /FOR THE ORDER OF | Zimbabwe | Tablet | 1.5K | NOS | $1.81 | $3K | MUMBAI AIR (SAHAR) | HARARE | AIR |
| SUPPLIER #12 — MDS ENTERPRISES · 3 shipments · $3K | |||||||||||
| 27 | Nov 2025 | UNLISTED BUYER | Ghana | Tablet | 15 | NOS | $13.84 | $207.63 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 28 | Nov 2025 | UNLISTED BUYER | Ghana | Tablet | 100 | NOS | $15.76 | $2K | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 29 | Dec 2025 | UNLISTED BUYER | Ghana | Tablet | 50 | NOS | $17.51 | $875.51 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #13 — RUTVA MEDICARE · 7 shipments · $2K | |||||||||||
| 30 | Oct 2025 | UNLISTED BUYER | Zimbabwe | 100 | PCS | $2.61 | $260.59 | AHMEDABAD AIR | HARARE | AIR | |
| 31 | Oct 2025 | UNLISTED BUYER | Zimbabwe | 80 | PCS | $2.61 | $208.47 | AHMEDABAD AIR | HARARE | AIR | |
| 32 | Oct 2025 | UNLISTED BUYER | Zimbabwe | 50 | PCS | $1.36 | $68.16 | AHMEDABAD AIR | HARARE | AIR | |
| 33 | Dec 2025 | UNLISTED BUYER | Zimbabwe | Tablet | 60 | PCS | $8.67 | $520.45 | AHMEDABAD AIR | HARARE | AIR |
| 34 | Dec 2025 | UNLISTED BUYER | Zimbabwe | Tablet | 100 | PCS | $8.67 | $867.43 | AHMEDABAD AIR | HARARE | AIR |
| 35 | Dec 2025 | UNLISTED BUYER | Ghana | 420 | NOS | $0.013 | $5.50 | MUMBAI AIR (SAHAR) | ACCRA | AIR | |
| 36 | Dec 2025 | UNLISTED BUYER | Ghana | Tablet | 180 | NOS | $0.013 | $2.36 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #14 — 3S CORP · 2 shipments · $1K | |||||||||||
| 37 | Nov 2025 | FOR THE ORDER OF | Kenya | Tablet | 800 | NOS | $1.29 | $1K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 38 | Dec 2025 | FOR THE ORDER OF | Kenya | Tablet | 50 | NOS | $3.01 | $150.71 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #15 — MELON GLOBALCARE · 1 shipments · $874.62 | |||||||||||
| 39 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 500 | NOS | $1.75 | $874.62 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #16 — BRUCK PHARMA PVT LTD · 2 shipments · $729.07 | |||||||||||
| 40 | Dec 2025 | UNLISTED BUYER | Burundi | Tablet | 300 | NOS | $2.43 | $729.00 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| 41 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Tablet | 3 | NOS | $0.024 | $0.071 | MUMBAI AIR (SAHAR) | ABIDJAN | AIR |
| SUPPLIER #17 — RMPL PHARMA LLP · 1 shipments · $715.55 | |||||||||||
| 42 | Nov 2025 | UNLISTED BUYER | Kenya | Tablet | 500 | NOS | $1.43 | $715.55 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #18 — SUDDHASATTWA RAY · 1 shipments · $700.80 | |||||||||||
| 43 | Nov 2025 | CAMEROON ONCOLOGY CENTRE IN DOUALA | Cameroon | Tablet | 400 | PCS | $1.75 | $700.80 | KOLKATA AIR | DOUALA | AIR |
| SUPPLIER #19 — M T MADON EXPORTS · 1 shipments · $670.72 | |||||||||||
| 44 | Dec 2025 | SALAMA PHARMACUTICALS LTD | Kenya | Tablet | 500 | NOS | $1.34 | $670.72 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #20 — KLV HEALTHCARE PVT LTD · 1 shipments · $630.00 | |||||||||||
| 45 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 300 | NOS | $2.10 | $630.00 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #21 — RUN MEDWAY · 1 shipments · $489.57 | |||||||||||
| 46 | Dec 2025 | CLYZ PHARMA SARL | Cameroon | Tablet | 400 | NOS | $1.22 | $489.57 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #22 — AMARI TRADE ALLIANCE LLP · 1 shipments · $248.53 | |||||||||||
| 47 | Nov 2025 | ABU AHMED | Kenya | Tablet | 200 | NOS | $1.24 | $248.53 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #23 — COSMOS PHARMA · 1 shipments · $133.62 | |||||||||||
| 48 | Dec 2025 | UNLISTED BUYER | DR Congo | Tablet | 17 | NOS | $7.86 | $133.62 | MUMBAI AIR (SAHAR) | LUMBUMBASHI | AIR |
| SUPPLIER #24 — BIOZENTA LIFESCIENCE PVT LTD · 1 shipments · $74.70 | |||||||||||
| 49 | Dec 2025 | UNLISTED BUYER | Egypt | Tablet | 41.0K | NOS | $0.0018 | $74.70 | DELHI AIR | CAIRO | AIR |
| SUPPLIER #25 — J.A. UNITED EXPORTS PVT LTD · 1 shipments · $58.09 | |||||||||||
| 50 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Tablet | 3.0K | NOS | $0.019 | $58.09 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
| SUPPLIER #26 — EXGEN CARE PVT LTD · 1 shipments · $15.37 | |||||||||||
| 51 | Dec 2025 | UNLISTED BUYER | Angola | Tablet | 10 | NOS | $1.54 | $15.37 | DELHI AIR | LUANDA - | AIR |
| SUPPLIER #27 — S. HIMATLAL HEALTHCARE LLP · 5 shipments · $11.47 | |||||||||||
| 52 | Dec 2025 | UNLISTED BUYER | Ethiopia | Tablet | 110 | NOS | $0.011 | $1.26 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 53 | Dec 2025 | UNLISTED BUYER | Ethiopia | Tablet | 60 | NOS | $0.011 | $0.688 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 54 | Dec 2025 | UNLISTED BUYER | Ethiopia | Tablet | 30 | NOS | $0.011 | $0.344 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 55 | Dec 2025 | UNLISTED BUYER | Ethiopia | Tablet | 320 | NOS | $0.011 | $3.67 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 56 | Dec 2025 | UNLISTED BUYER | Ethiopia | Tablet | 480 | NOS | $0.011 | $5.51 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #28 — GRAMEEN PHARMA LLP · 1 shipments · $4.70 | |||||||||||
| 57 | Dec 2025 | THE MANAGER SA | Ghana | Tablet | 300 | NOS | $0.016 | $4.70 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #29 — EUGIA PHARMA SPECIALITIES LTD · 1 shipments · $4.41 | |||||||||||
| 58 | Oct 2025 | GENERICS & SPECIALITIES LTD | Tanzania | Tablet | 5.3K | NOS | $0.0008 | $4.41 | HYDERABAD ICD | DAR ES SALAAM | ICD |
| SUPPLIER #30 — YOGI CARE PHARMACEUTICAL PVT LTD · 1 shipments · $4.31 | |||||||||||
| 59 | Oct 2025 | UNLISTED BUYER | DR Congo | Tablet | 10 | NOS | $0.431 | $4.31 | AHMEDABAD AIR | LUMBUMBASHI | AIR |
| SUPPLIER #31 — SANSKRUTI PHARMA · 1 shipments · $1.88 | |||||||||||
| 60 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Tablet | 50 | NOS | $0.038 | $1.88 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #32 — NUMED PHARMA DISTRIBUTOR · 1 shipments · $0.0000 | |||||||||||
| 61 | Nov 2025 | LIFELINE PHARMACEUTICALS OF | Lesotho | Capsule | 2.1K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
15 countries · 70 shipments · $465K · 25 Indian suppliers · 14 buyers
SHIPMENTS
70
USD
$465K
COUNTRIES
15
SUPPLIERS
25
BUYERS
14
HHI
1,865
moderate
Top 15 destination countries in Asia
1
Hong Kong (30.7%)
$143K
2
Philippines (18.0%)
$83K
3
Israel (17.9%)
$83K
4
Cambodia (14.4%)
$67K
5
Afghanistan (8.8%)
$41K
6
Nepal (4.8%)
$22K
7
Tajikistan (3.3%)
$15K
8
Myanmar (1.2%)
$6K
9
Singapore (0.5%)
$2K
10
China (0.3%)
$2K
11
Turkey (0.1%)
$537.33
12
Oman (0.0%)
$70.95
13
Maldives (0.0%)
$21.63
14
United Arab Emirates (0.0%)
$19.58
15
Laos (0.0%)
$17.50
Top 25 Indian suppliers into Asia
1
INTAS PHARMACEUTICALS LTD
$143K
2
BETA DRUGS LTD
$83K
3
SUN PHARMACEUTICAL INDUSTRIES LTD
$83K
4
FLORENCIA HEALTHCARE
$65K
5
RESCUERS LIFE SCIENCES LTD
$37K
6
GALAXY SUPER SPECIALITY
$15K
7
RELIANCE LIFE SCIENCES PVT LTD
$15K
8
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD
$6K
9
BIOZENTA LIFESCIENCE PVT LTD
$6K
10
KWALITY PHARMACEUTICALS LTD
$4K
11
LEOWIN HEALTHCARE LLP
$2K
12
UNITED BIOTECH PVT LTD
$2K
13
JMB PHARMACEUTICALS PVT LTD
$2K
14
BRUCK PHARMA PVT LTD
$1K
15
RMPL PHARMA LLP
$537.33
16
VANDAN HEALTHCARE
$507.42
17
K. K. PHARMA SOLUTIONS
$217.62
18
MEDMATRIX ASSOCIATES
$153.08
19
M CARE
$70.95
20
KHANDELWAL LABORATORIES PVT LTD
$40.29
21
MC PHARMA DISTRIBUTORS
$21.63
22
MDS ENTERPRISES
$19.36
23
ONCOHEAL HEALTHCARE LLP
$17.50
24
MOVID IMPEX
$0.218
25
VATS INDUSTRIES PVT LTD
$0.0000
Top 12 Asia importers
1
2 MG INC · Philippines
$83K
2
ETEMED MOSLEH LTD · Afghanistan
$37K
3
PHARMACHEM PVT LTD · Nepal
$15K
4
AM BIOTECH PVT LTD · Nepal
$6K
5
TRUST ANESTHETIC LTD · Afghanistan
$4K
6
DALIAN CHAOHONGSUPPLY CHAIN MANAGEM · China
$2K
7
NIKHIL PHARMA PVT LTD · Nepal
$975.29
8
2MG INC · Philippines
$583.59
9
GULF IMPEX FZC · Afghanistan
$153.08
10
BISTRA PHARMA LINK PVT LTD · Nepal
$40.29
11
STATE TRADING ORGANIZATION PLC · Maldives
$21.63
12
EMIRATES POST GROUP · United Arab Emirates
$0.218
Top 2 dosage forms
1
Tablet
$322K
2
Unknown
$143K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $2K | $821.56 |
| Nov | 32 | $412K | $13K |
| Dec | 36 | $51K | $1K |
Shipment register · 70 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INTAS PHARMACEUTICALS LTD · 6 shipments · $143K | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Hong Kong | 114.8K | TBS | $0.076 | $9K | AHMEDABAD AIR | HONG KONG | AIR | |
| 2 | Nov 2025 | UNLISTED BUYER | Hong Kong | 113.8K | TBS | $0.233 | $27K | AHMEDABAD AIR | HONG KONG | AIR | |
| 3 | Nov 2025 | UNLISTED BUYER | Hong Kong | 115.3K | TBS | $0.233 | $27K | AHMEDABAD AIR | HONG KONG | AIR | |
| 4 | Nov 2025 | UNLISTED BUYER | Hong Kong | 116.0K | TBS | $0.233 | $27K | AHMEDABAD AIR | HONG KONG | AIR | |
| 5 | Nov 2025 | UNLISTED BUYER | Hong Kong | 115.6K | TBS | $0.233 | $27K | AHMEDABAD AIR | HONG KONG | AIR | |
| 6 | Nov 2025 | UNLISTED BUYER | Hong Kong | 113.3K | TBS | $0.233 | $26K | AHMEDABAD AIR | HONG KONG | AIR | |
| SUPPLIER #2 — BETA DRUGS LTD · 21 shipments · $83K | |||||||||||
| 7 | Nov 2025 | 2 MG INC | Philippines | Tablet | 462 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 8 | Nov 2025 | 2 MG INC | Philippines | Tablet | 462 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 9 | Nov 2025 | 2 MG INC | Philippines | Tablet | 462 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 10 | Nov 2025 | 2 MG INC | Philippines | Tablet | 462 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 11 | Nov 2025 | 2 MG INC | Philippines | Tablet | 462 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 12 | Nov 2025 | 2 MG INC | Philippines | Tablet | 464 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 13 | Nov 2025 | 2 MG INC | Philippines | Tablet | 463 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 14 | Nov 2025 | 2 MG INC | Philippines | Tablet | 464 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 15 | Nov 2025 | 2 MG INC | Philippines | Tablet | 464 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 16 | Nov 2025 | 2 MG INC | Philippines | Tablet | 464 | NOS | $16.57 | $8K | DELHI AIR | MANILA | AIR |
| 17 | Nov 2025 | 2 MG INC | Philippines | Tablet | 371 | NOS | $16.57 | $6K | DELHI AIR | MANILA | AIR |
| 18 | Dec 2025 | 2MG INC | Philippines | Tablet | 80 | NOS | $0.192 | $15.35 | DELHI AIR | MANILA | AIR |
| 19 | Dec 2025 | 2MG INC | Philippines | Tablet | 458 | NOS | $0.192 | $87.90 | DELHI AIR | MANILA | AIR |
| 20 | Dec 2025 | 2MG INC | Philippines | Tablet | 462 | NOS | $0.192 | $88.66 | DELHI AIR | MANILA | AIR |
| 21 | Dec 2025 | 2MG INC | Philippines | Tablet | 4 | NOS | $0.192 | $0.767 | DELHI AIR | MANILA | AIR |
| 22 | Dec 2025 | 2MG INC | Philippines | Tablet | 462 | NOS | $0.192 | $88.61 | DELHI AIR | MANILA | AIR |
| 23 | Dec 2025 | 2MG INC | Philippines | Tablet | 461 | NOS | $0.192 | $88.42 | DELHI AIR | MANILA | AIR |
| 24 | Dec 2025 | 2MG INC | Philippines | Tablet | 73 | NOS | $0.192 | $14.00 | DELHI AIR | MANILA | AIR |
| 25 | Dec 2025 | 2MG INC | Philippines | Tablet | 390 | NOS | $0.192 | $74.81 | DELHI AIR | MANILA | AIR |
| 26 | Dec 2025 | 2MG INC | Philippines | Tablet | 462 | NOS | $0.192 | $88.62 | DELHI AIR | MANILA | AIR |
| 27 | Dec 2025 | 2MG INC | Philippines | Tablet | 190 | NOS | $0.192 | $36.44 | DELHI AIR | MANILA | AIR |
| SUPPLIER #3 — SUN PHARMACEUTICAL INDUSTRIES LTD · 2 shipments · $83K | |||||||||||
| 28 | Nov 2025 | UNKNOWN BUYER | Israel | Tablet | 164.8K | NOS | $0.261 | $43K | MUMBAI AIR (SAHAR) | TEL AVIV YAFO | AIR |
| 29 | Nov 2025 | UNKNOWN BUYER | Israel | Tablet | 164.8K | NOS | $0.243 | $40K | MUMBAI AIR (SAHAR) | TEL AVIV YAFO | AIR |
| SUPPLIER #4 — FLORENCIA HEALTHCARE · 1 shipments · $65K | |||||||||||
| 30 | Nov 2025 | UNLISTED BUYER | Cambodia | Tablet | 5.5K | NOS | $11.80 | $65K | DELHI AIR | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #5 — RESCUERS LIFE SCIENCES LTD · 3 shipments · $37K | |||||||||||
| 31 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Tablet | 10.0K | NOS | $1.22 | $12K | DELHI AIR | KABUL | AIR |
| 32 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Tablet | 10.0K | NOS | $1.22 | $12K | DELHI AIR | KABUL | AIR |
| 33 | Dec 2025 | ETEMED MOSLEH LTD | Afghanistan | Tablet | 10.0K | NOS | $1.22 | $12K | DELHI AIR | KABUL | AIR |
| SUPPLIER #6 — GALAXY SUPER SPECIALITY · 2 shipments · $15K | |||||||||||
| 34 | Nov 2025 | UNLISTED BUYER | Tajikistan | Tablet | 4.3K | NOS | $1.93 | $8K | DELHI AIR | TASHKENT | AIR |
| 35 | Nov 2025 | UNLISTED BUYER | Tajikistan | Tablet | 3.7K | NOS | $1.93 | $7K | DELHI AIR | TASHKENT | AIR |
| SUPPLIER #7 — RELIANCE LIFE SCIENCES PVT LTD · 1 shipments · $15K | |||||||||||
| 36 | Nov 2025 | PHARMACHEM PVT LTD | Nepal | Tablet | 6.0K | NOS | $2.43 | $15K | RAXAUL | Birgunj | ROAD |
| SUPPLIER #8 — BDR PHARMACEUTICALS INTERNATIONAL PVT LTD · 3 shipments · $6K | |||||||||||
| 37 | Nov 2025 | AM BIOTECH PVT LTD | Nepal | Tablet | 140 | NOS | $2.19 | $306.95 | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | AIR |
| 38 | Dec 2025 | AM BIOTECH PVT LTD | Nepal | Tablet | 140 | NOS | $2.20 | $307.30 | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | AIR |
| 39 | Dec 2025 | AM BIOTECH PVT LTD | Nepal | Tablet | 2.4K | NOS | $2.16 | $5K | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | SEA |
| SUPPLIER #9 — BIOZENTA LIFESCIENCE PVT LTD · 1 shipments · $6K | |||||||||||
| 40 | Dec 2025 | UNLISTED BUYER | Myanmar | Tablet | 500 | NOS | $11.23 | $6K | DELHI AIR | YANGON | AIR |
| SUPPLIER #10 — KWALITY PHARMACEUTICALS LTD · 2 shipments · $4K | |||||||||||
| 41 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Tablet | 15.0K | NOS | $0.134 | $2K | DELHI AIR | KABUL | AIR |
| 42 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Tablet | 15.0K | NOS | $0.134 | $2K | DELHI AIR | KABUL | AIR |
| SUPPLIER #11 — LEOWIN HEALTHCARE LLP · 1 shipments · $2K | |||||||||||
| 43 | Dec 2025 | UNLISTED BUYER | Singapore | Tablet | 140 | NOS | $14.29 | $2K | AHMEDABAD AIR | SINGAPORE | AIR |
| SUPPLIER #12 — UNITED BIOTECH PVT LTD · 2 shipments · $2K | |||||||||||
| 44 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | Tablet | 150 | PCS | $6.50 | $975.29 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 45 | Nov 2025 | UNKNOWN BUYER | Nepal | Tablet | 150 | PCS | $6.50 | $975.29 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #13 — JMB PHARMACEUTICALS PVT LTD · 3 shipments · $2K | |||||||||||
| 46 | Oct 2025 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | Tablet | 1.0K | NOS | $1.62 | $2K | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 47 | Dec 2025 | UNLISTED BUYER | China | Tablet | 300 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 48 | Dec 2025 | UNLISTED BUYER | China | Tablet | 300 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| SUPPLIER #14 — BRUCK PHARMA PVT LTD · 2 shipments · $1K | |||||||||||
| 49 | Nov 2025 | UNLISTED BUYER | Cambodia | Tablet | 200 | NOS | $3.53 | $705.23 | MUMBAI AIR (SAHAR) | PHNOM PENH - POCHENT | AIR |
| 50 | Nov 2025 | UNLISTED BUYER | Cambodia | Tablet | 200 | NOS | $3.53 | $705.23 | MUMBAI AIR (SAHAR) | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #15 — RMPL PHARMA LLP · 2 shipments · $537.33 | |||||||||||
| 51 | Nov 2025 | UNLISTED BUYER | Turkey | Tablet | 360 | NOS | $1.47 | $527.66 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| 52 | Dec 2025 | UNLISTED BUYER | Turkey | Tablet | 600 | NOS | $0.016 | $9.67 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #16 — VANDAN HEALTHCARE · 1 shipments · $507.42 | |||||||||||
| 53 | Nov 2025 | UNLISTED BUYER | Cambodia | Tablet | 100 | NOS | $5.07 | $507.42 | AHMEDABAD AIR | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #17 — K. K. PHARMA SOLUTIONS · 4 shipments · $217.62 | |||||||||||
| 54 | Dec 2025 | UNLISTED BUYER | Singapore | Tablet | 30 | NOS | $2.18 | $65.29 | AHMEDABAD AIR | SINGAPORE | AIR |
| 55 | Dec 2025 | UNLISTED BUYER | Singapore | Tablet | 20 | NOS | $2.18 | $43.53 | AHMEDABAD AIR | SINGAPORE | AIR |
| 56 | Dec 2025 | UNLISTED BUYER | Singapore | 30 | NOS | $2.18 | $65.28 | AHMEDABAD AIR | SINGAPORE | AIR | |
| 57 | Dec 2025 | UNLISTED BUYER | Singapore | 20 | NOS | $2.18 | $43.52 | AHMEDABAD AIR | SINGAPORE | AIR | |
| SUPPLIER #18 — MEDMATRIX ASSOCIATES · 1 shipments · $153.08 | |||||||||||
| 58 | Dec 2025 | GULF IMPEX FZC | Afghanistan | Tablet | 1.5K | NOS | $0.102 | $153.08 | DADRI ICD | KABUL | ICD |
| SUPPLIER #19 — M CARE · 1 shipments · $70.95 | |||||||||||
| 59 | Dec 2025 | UNLISTED BUYER | Oman | Tablet | 3 | PCS | $23.65 | $70.95 | DELHI AIR | MUSCAT | AIR |
| SUPPLIER #20 — KHANDELWAL LABORATORIES PVT LTD · 2 shipments · $40.29 | |||||||||||
| 60 | Dec 2025 | BISTRA PHARMA LINK PVT LTD | Nepal | Tablet | 190 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | AIR |
| 61 | Dec 2025 | BISTRA PHARMA LINK PVT LTD | Nepal | Tablet | 10 | NOS | $4.03 | $40.29 | MUMBAI AIR (SAHAR) | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #21 — MC PHARMA DISTRIBUTORS · 1 shipments · $21.63 | |||||||||||
| 62 | Oct 2025 | STATE TRADING ORGANIZATION PLC | Maldives | Tablet | 90 | NOS | $0.240 | $21.63 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #22 — MDS ENTERPRISES · 3 shipments · $19.36 | |||||||||||
| 63 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 50 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 64 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 50 | NOS | $0.159 | $7.97 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| 65 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 50 | NOS | $0.228 | $11.39 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| SUPPLIER #23 — ONCOHEAL HEALTHCARE LLP · 2 shipments · $17.50 | |||||||||||
| 66 | Dec 2025 | UNKNOWN BUYER | Laos | Tablet | 300 | NOS | $0.016 | $4.66 | MUMBAI AIR (SAHAR) | VIENTIANE | SEA |
| 67 | Dec 2025 | UNLISTED BUYER | Laos | Tablet | 600 | NOS | $0.021 | $12.84 | MUMBAI AIR (SAHAR) | VIENTIANE | AIR |
| SUPPLIER #24 — MOVID IMPEX · 2 shipments · $0.218 | |||||||||||
| 68 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 4 | NOS | $0.044 | $0.174 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 69 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 1 | NOS | $0.044 | $0.044 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #25 — VATS INDUSTRIES PVT LTD · 1 shipments · $0.0000 | |||||||||||
| 70 | Dec 2025 | TRUST ANESTHETIC LTD | Afghanistan | Tablet | 5.0K | NOS | $0.0000 | $0.0000 | DELHI AIR | KABUL | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
13 countries · 52 shipments · $348K · 12 Indian suppliers · 12 buyers
SHIPMENTS
52
USD
$348K
COUNTRIES
13
SUPPLIERS
12
BUYERS
12
HHI
3,906
concentrated
Top 13 destination countries in Americas
1
United States (34.0%)
$118K
2
Brazil (30.7%)
$107K
3
Canada (21.2%)
$74K
4
Uruguay (7.2%)
$25K
5
Paraguay (3.3%)
$12K
6
Venezuela (1.3%)
$5K
7
Antigua and Barbuda (0.6%)
$2K
8
Bahamas (0.6%)
$2K
9
Haiti (0.4%)
$2K
10
Saint Vincent and the Grenadines (0.3%)
$1K
11
Cayman Islands (0.1%)
$428.57
12
Barbados (0.1%)
$320.69
13
Saint Kitts and Nevis (0.0%)
$71.44
Top 12 Indian suppliers into Americas
1
SUN PHARMACEUTICAL INDUSTRIES LTD
$180K
2
ALKEM LABORATORIES LTD
$118K
3
BDR PHARMACEUTICALS INTERNATIONAL PVT LTD
$25K
4
RELIANCE LIFE SCIENCES PVT LTD
$12K
5
AMRS HEALTHCARE PVT LTD
$4K
6
SPR ONCOCARE PVT LTD
$2K
7
KHANDELWAL LABORATORIES PVT LTD
$2K
8
DOSSMEGT PHARMACEUTICALS PVT LTD
$2K
9
BRINTON PHARMACEUTICALS LTD
$1K
10
SANDOZ PVT LTD
$504.48
11
AANYA GLOBAL
$428.57
12
GALAXY SUPER SPECIALITY
$198.08
Top 10 Americas importers
1
SUN FARMACEUTICA DO BRASIL LTDA · Brazil
$107K
2
M/S.SUN PHARMA CANADA INC · Canada
$73K
3
ASCEND LABORATORIES LLC · United States
$72K
4
NPINSA · Uruguay
$25K
5
BIOTENG S.A · Paraguay
$6K
6
BRYDEN A S & SONS ANU LTD · Antigua and Barbuda
$2K
7
HAZMAC BAHAMAS · Bahamas
$2K
8
HOPITAL CARAMED CLINIQUE DU CANCE · Haiti
$2K
9
SANDOZ CANADA INC · Canada
$504.48
10
WELLPOINT MEDICAL & ONCOLOGY CENTER · Saint Kitts and Nevis
$71.44
Top 2 dosage forms
1
Tablet
$294K
2
Unknown
$54K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $75K | $38K |
| Nov | 10 | $134K | $13K |
| Dec | 40 | $138K | $3K |
Shipment register · 52 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SUN PHARMACEUTICAL INDUSTRIES LTD · 2 shipments · $180K | |||||||||||
| 1 | Oct 2025 | M/S.SUN PHARMA CANADA INC | Canada | Tablet | 118.7K | NOS | $0.617 | $73K | DHANNAD ICD | Newark | ICD |
| 2 | Dec 2025 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | Tablet | 530.2K | NOS | $0.202 | $107K | DELHI AIR | RIO DE JANEIRO - GAL | AIR |
| SUPPLIER #2 — ALKEM LABORATORIES LTD · 4 shipments · $118K | |||||||||||
| 3 | Nov 2025 | ASCEND LABORATORIES LLC | United States | 3.0K | NOS | $15.57 | $46K | NHAVA SHEVA SEA (JNPT) | Newark | SEA | |
| 4 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 3.0K | NOS | $15.57 | $46K | NHAVA SHEVA SEA (JNPT) | Newark | SEA |
| 5 | Nov 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 1.2K | NOS | $15.42 | $18K | NHAVA SHEVA SEA (JNPT) | Newark Apt/New York | SEA |
| 6 | Nov 2025 | ASCEND LABORATORIES LLC | United States | 1.9K | NOS | $3.75 | $7K | NHAVA SHEVA SEA (JNPT) | Newark | SEA | |
| SUPPLIER #3 — BDR PHARMACEUTICALS INTERNATIONAL PVT LTD · 1 shipments · $25K | |||||||||||
| 7 | Dec 2025 | NPINSA | Uruguay | Tablet | 11.6K | NOS | $2.18 | $25K | MUMBAI AIR (SAHAR) | MONTEVIDEO - | AIR |
| SUPPLIER #4 — RELIANCE LIFE SCIENCES PVT LTD · 2 shipments · $12K | |||||||||||
| 8 | Nov 2025 | BIOTENG S.A | Paraguay | Tablet | 1.9K | NOS | $3.06 | $6K | MUMBAI AIR (SAHAR) | ASUNCION | AIR |
| 9 | Nov 2025 | UNKNOWN BUYER | Paraguay | Tablet | 1.9K | NOS | $3.06 | $6K | MUMBAI AIR (SAHAR) | ASUNCION | AIR |
| SUPPLIER #5 — AMRS HEALTHCARE PVT LTD · 33 shipments · $4K | |||||||||||
| 10 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 11 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 12 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 16 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 37.2K | NOS | $0.0030 | $110.29 | DELHI AIR | CARACAS | AIR |
| 17 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.5K | NOS | $0.0030 | $137.87 | DELHI AIR | CARACAS | AIR |
| 18 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 19 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 20 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.0K | NOS | $0.0030 | $136.38 | DELHI AIR | CARACAS | AIR |
| 21 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.5K | NOS | $0.0030 | $137.87 | DELHI AIR | CARACAS | AIR |
| 22 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 25.6K | NOS | $0.0030 | $75.90 | DELHI AIR | CARACAS | AIR |
| 23 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.7K | NOS | $0.0030 | $138.46 | DELHI AIR | CARACAS | AIR |
| 24 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.7K | NOS | $0.0030 | $138.46 | DELHI AIR | CARACAS | AIR |
| 25 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.5K | NOS | $0.0030 | $137.87 | DELHI AIR | CARACAS | AIR |
| 26 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.5K | NOS | $0.0030 | $137.87 | DELHI AIR | CARACAS | AIR |
| 27 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.5K | NOS | $0.0030 | $137.87 | DELHI AIR | CARACAS | AIR |
| 28 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.6K | NOS | $0.0030 | $138.16 | DELHI AIR | CARACAS | AIR |
| 29 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.6K | NOS | $0.0030 | $138.16 | DELHI AIR | CARACAS | AIR |
| 30 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.5K | NOS | $0.0030 | $137.87 | DELHI AIR | CARACAS | AIR |
| 31 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 45.9K | NOS | $0.0030 | $136.09 | DELHI AIR | CARACAS | AIR |
| 32 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.4K | NOS | $0.0030 | $137.57 | DELHI AIR | CARACAS | AIR |
| 33 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 34 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 35 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.5K | NOS | $0.0030 | $137.87 | DELHI AIR | CARACAS | AIR |
| 36 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 37 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 38 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.2K | NOS | $0.0030 | $136.98 | DELHI AIR | CARACAS | AIR |
| 39 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.5K | NOS | $0.0030 | $137.87 | DELHI AIR | CARACAS | AIR |
| 40 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.6K | NOS | $0.0030 | $138.16 | DELHI AIR | CARACAS | AIR |
| 41 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.5K | NOS | $0.0030 | $137.87 | DELHI AIR | CARACAS | AIR |
| 42 | Dec 2025 | UNLISTED BUYER | Venezuela | Tablet | 46.6K | NOS | $0.0030 | $138.16 | DELHI AIR | CARACAS | AIR |
| SUPPLIER #6 — SPR ONCOCARE PVT LTD · 2 shipments · $2K | |||||||||||
| 43 | Oct 2025 | BRYDEN A S & SONS ANU LTD | Antigua and Barbuda | Tablet | 6.0K | TBS | $0.350 | $2K | BANGALORE AIR | ANTIGUA | AIR |
| 44 | Dec 2025 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | Tablet | 200 | NOS | $0.357 | $71.44 | BANGALORE AIR | NEVIS | AIR |
| SUPPLIER #7 — KHANDELWAL LABORATORIES PVT LTD · 1 shipments · $2K | |||||||||||
| 45 | Nov 2025 | HAZMAC BAHAMAS | Bahamas | Tablet | 1.0K | NOS | $2.00 | $2K | MUMBAI AIR (SAHAR) | NASSAU | AIR |
| SUPPLIER #8 — DOSSMEGT PHARMACEUTICALS PVT LTD · 1 shipments · $2K | |||||||||||
| 46 | Nov 2025 | HOPITAL CARAMED CLINIQUE DU CANCE | Haiti | Tablet | 50 | NOS | $30.71 | $2K | MUMBAI AIR (SAHAR) | PORT AU PRINCE | AIR |
| SUPPLIER #9 — BRINTON PHARMACEUTICALS LTD · 3 shipments · $1K | |||||||||||
| 47 | Dec 2025 | UNLISTED BUYER | Barbados | Tablet | 100 | NOS | $3.21 | $320.69 | MUMBAI AIR (SAHAR) | BRIDGETOWN | AIR |
| 48 | Dec 2025 | UNLISTED BUYER | Saint Vincent and the Grenadines | Tablet | 260 | NOS | $2.86 | $743.61 | MUMBAI AIR (SAHAR) | ST VINCENT | AIR |
| 49 | Dec 2025 | UNLISTED BUYER | Saint Vincent and the Grenadines | Tablet | 100 | NOS | $2.86 | $286.00 | MUMBAI AIR (SAHAR) | ST VINCENT | AIR |
| SUPPLIER #10 — SANDOZ PVT LTD · 1 shipments · $504.48 | |||||||||||
| 50 | Dec 2025 | SANDOZ CANADA INC | Canada | Tablet | 1.9K | PCS | $0.270 | $504.48 | NHAVA SHEVA SEA (JNPT) | Montreal | SEA |
| SUPPLIER #11 — AANYA GLOBAL · 1 shipments · $428.57 | |||||||||||
| 51 | Nov 2025 | UNLISTED BUYER | Cayman Islands | Tablet | 90 | PCS | $4.76 | $428.57 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #12 — GALAXY SUPER SPECIALITY · 1 shipments · $198.08 | |||||||||||
| 52 | Nov 2025 | UNLISTED BUYER | Venezuela | Tablet | 75 | NOS | $2.64 | $198.08 | DELHI AIR | MADRID | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $954.17 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$954.17
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$954.17
Top 1 Indian suppliers into Oceania
1
BRUCK PHARMA PVT LTD
$954.17
Top 0 Oceania importers
Top 1 dosage forms
1
Tablet
$954.17
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $954.17 | $954.17 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BRUCK PHARMA PVT LTD · 1 shipments · $954.17 | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Papua New Guinea | Tablet | 50 | NOS | $19.08 | $954.17 | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 59 Indian capecitabine exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped capecitabine in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LTD | AHMEDABAD | 11 | $274K | Tablet | Africa, Asia |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LTD | MUMBAI | 4 | $263K | Tablet | Americas, Asia |
| 3 | CIPLA LTD | PAREL MUMBAI MAHARASHTRA | 6 | $234K | Tablet | Africa |
| 4 | ALKEM LABORATORIES LTD | Panvel | 4 | $118K | Tablet | Americas |
| 5 | BETA DRUGS LTD | BADDI | 21 | $83K | Tablet | Asia |
| 6 | FLORENCIA HEALTHCARE | NOIDA | 1 | $65K | Tablet | Asia |
| 7 | RESCUERS LIFE SCIENCES LTD | NALAGARH ROAD BADDI | 3 | $37K | Tablet | Asia |
| 8 | BDR PHARMACEUTICALS INTERNATIONAL PVT LTD | MUMBAI | 4 | $31K | Tablet | Asia, Americas |
| 9 | RELIANCE LIFE SCIENCES PVT LTD | NAVI MUMBAI MAHARASHTRA | 3 | $26K | Tablet | Asia, Americas |
| 10 | AASHVI PHARMACEUTICALS PVT LTD | Ahmedabad | 2 | $17K | Tablet | Africa |
| 11 | GALAXY SUPER SPECIALITY | NEW DELHI | 3 | $16K | Tablet | Asia, Americas |
| 12 | NEOPHAR PHARMACEUTICALS PVT LTD | DELHI | 2 | $9K | Tablet | Africa |
| 13 | FLORENCIA HEALTHCARE PVT LTD | NOIDA | 3 | $8K | Tablet | Africa |
| 14 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 2 | $6K | Tablet | Africa |
| 15 | PHARMEDA HEALTHCARE PVT LTD | NEW DELHI | 2 | $6K | Tablet | Africa |
| 16 | BIOZENTA LIFESCIENCE PVT LTD | Una | 2 | $6K | Tablet | Asia, Africa |
| 17 | PIRZE LIFECARE PVT LTD | AHMEDABAD | 1 | $5K | Africa | |
| 18 | AMRS HEALTHCARE PVT LTD | NOIDA | 33 | $4K | Tablet | Americas |
| 19 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 2 | $4K | Tablet | Asia |
| 20 | LIFENEST PHARMA LLP | Mumbai | 1 | $3K | Capsule | Africa |
| 21 | ASPIRA BIOHEALTH LLP | SALEM | 1 | $3K | Tablet | Africa |
| 22 | BRUCK PHARMA PVT LTD | NANI | 5 | $3K | Tablet | Asia, Africa |
| 23 | 3S PHARMACEUTICALS INDIA PVT LTD | MUMBAI | 1 | $3K | Tablet | Africa |
| 24 | MDS ENTERPRISES | MUMBAI | 6 | $3K | Tablet | Africa, Asia |
| 25 | SPR ONCOCARE PVT LTD | BANGALORE | 2 | $2K | Tablet | Americas |
| 26 | KHANDELWAL LABORATORIES PVT LTD | THANE | 3 | $2K | Tablet | Americas, Asia |
| 27 | LEOWIN HEALTHCARE LLP | GANDHINAGAR | 1 | $2K | Tablet | Asia |
| 28 | UNITED BIOTECH PVT LTD | NEW DELHI | 2 | $2K | Tablet | Asia |
| 29 | RUTVA MEDICARE | SURAT | 7 | $2K | Tablet | Africa |
| 30 | JMB PHARMACEUTICALS PVT LTD | MUMBAI | 3 | $2K | Tablet | Asia |
| 31 | DOSSMEGT PHARMACEUTICALS PVT LTD | MULUND WEST | 1 | $2K | Tablet | Americas |
| 32 | BRINTON PHARMACEUTICALS LTD | PUNE | 3 | $1K | Tablet | Americas |
| 33 | RMPL PHARMA LLP | MUMBAI | 3 | $1K | Tablet | Africa, Asia |
| 34 | 3S CORP | MUMBAI | 2 | $1K | Tablet | Africa |
| 35 | MELON GLOBALCARE | MUMBAI | 1 | $874.62 | Tablet | Africa |
| 36 | SUDDHASATTWA RAY | BHOWANIPORE KOLKATA | 1 | $700.80 | Tablet | Africa |
| 37 | M T MADON EXPORTS | MUMBAI | 1 | $670.72 | Tablet | Africa |
| 38 | KLV HEALTHCARE PVT LTD | DAHISAR | 1 | $630.00 | Tablet | Africa |
| 39 | VANDAN HEALTHCARE | AHMEDABAD | 1 | $507.42 | Tablet | Asia |
| 40 | SANDOZ PVT LTD | Navi Mumbai | 1 | $504.48 | Tablet | Americas |
| 41 | RUN MEDWAY | SURAT | 1 | $489.57 | Tablet | Africa |
| 42 | AANYA GLOBAL | Mumbai | 1 | $428.57 | Tablet | Americas |
| 43 | AMARI TRADE ALLIANCE LLP | MUMBAI | 1 | $248.53 | Tablet | Africa |
| 44 | K. K. PHARMA SOLUTIONS | BANDRA EAST | 4 | $217.62 | Tablet | Asia |
| 45 | MEDMATRIX ASSOCIATES | AMBALA | 1 | $153.08 | Tablet | Asia |
| 46 | COSMOS PHARMA | BHAYANDER EAST | 1 | $133.62 | Tablet | Africa |
| 47 | M CARE | Aligarh | 1 | $70.95 | Tablet | Asia |
| 48 | J.A. UNITED EXPORTS PVT LTD | VASHI | 1 | $58.09 | Tablet | Africa |
| 49 | MC PHARMA DISTRIBUTORS | CHENNAI | 1 | $21.63 | Tablet | Asia |
| 50 | ONCOHEAL HEALTHCARE LLP | Ahmedabad | 2 | $17.50 | Tablet | Asia |
| 51 | EXGEN CARE PVT LTD | NOIDA | 1 | $15.37 | Tablet | Africa |
| 52 | S. HIMATLAL HEALTHCARE LLP | MUMBAI | 5 | $11.47 | Tablet | Africa |
| 53 | GRAMEEN PHARMA LLP | Mumbai | 1 | $4.70 | Tablet | Africa |
| 54 | EUGIA PHARMA SPECIALITIES LTD | MEDCHAL MALKAJIGIRI DIST | 1 | $4.41 | Tablet | Africa |
| 55 | YOGI CARE PHARMACEUTICAL PVT LTD | AHMEDABAD | 1 | $4.31 | Tablet | Africa |
| 56 | SANSKRUTI PHARMA | SURAT | 1 | $1.88 | Tablet | Africa |
| 57 | MOVID IMPEX | MUMBAI | 2 | $0.218 | Tablet | Asia |
| 58 | NUMED PHARMA DISTRIBUTOR | MANGAON | 1 | $0.0000 | Capsule | Africa |
| 59 | VATS INDUSTRIES PVT LTD | NEW DELHI | 1 | $0.0000 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 36 global capecitabine importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian capecitabine in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | 4 | $144K | CIPLA LTD | Tablet |
| 2 | SUN FARMACEUTICA DO BRASIL LTDA | Brazil | 1 | $107K | SUN PHARMACEUTICAL I… | Tablet |
| 3 | 2 MG INC | Philippines | 11 | $83K | BETA DRUGS LTD | Tablet |
| 4 | M/S.SUN PHARMA CANADA INC | Canada | 1 | $73K | SUN PHARMACEUTICAL I… | Tablet |
| 5 | ASCEND LABORATORIES LLC | United States | 3 | $72K | ALKEM LABORATORIES LTD | Tablet |
| 6 | ETEMED MOSLEH LTD | Afghanistan | 3 | $37K | RESCUERS LIFE SCIENC… | Tablet |
| 7 | NPINSA | Uruguay | 1 | $25K | BDR PHARMACEUTICALS … | Tablet |
| 8 | PHARMACHEM PVT LTD | Nepal | 1 | $15K | RELIANCE LIFE SCIENC… | Tablet |
| 9 | BIOTENG S.A | Paraguay | 1 | $6K | RELIANCE LIFE SCIENC… | Tablet |
| 10 | AM BIOTECH PVT LTD | Nepal | 3 | $6K | BDR PHARMACEUTICALS … | Tablet |
| 11 | DESH CHEMISTS LTD | Ghana | 1 | $6K | PHARMEDA HEALTHCARE … | Tablet |
| 12 | CENTRAIMED | Equatorial Guinea | 1 | $5K | PIRZE LIFECARE PVT LTD | |
| 13 | TRUST ANESTHETIC LTD | Afghanistan | 3 | $4K | KWALITY PHARMACEUTIC… | Tablet |
| 14 | PHILTA PHARMACY AND HEALTHCARE | Ghana | 1 | $3K | LIFENEST PHARMA LLP | Capsule |
| 15 | /FOR THE ORDER OF | Zimbabwe | 1 | $3K | 3S PHARMACEUTICALS I… | Tablet |
| 16 | BRYDEN A S & SONS ANU LTD | Antigua and Barbuda | 1 | $2K | SPR ONCOCARE PVT LTD | Tablet |
| 17 | HAZMAC BAHAMAS | Bahamas | 1 | $2K | KHANDELWAL LABORATOR… | Tablet |
| 18 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | 1 | $2K | JMB PHARMACEUTICALS … | Tablet |
| 19 | HOPITAL CARAMED CLINIQUE DU CANCE | Haiti | 1 | $2K | DOSSMEGT PHARMACEUTI… | Tablet |
| 20 | FOR THE ORDER OF | Kenya | 2 | $1K | 3S CORP | Tablet |
| 21 | NIKHIL PHARMA PVT LTD | Nepal | 1 | $975.29 | UNITED BIOTECH PVT LTD | Tablet |
| 22 | CAMEROON ONCOLOGY CENTRE IN DOUALA | Cameroon | 1 | $700.80 | SUDDHASATTWA RAY | Tablet |
| 23 | SALAMA PHARMACUTICALS LTD | Kenya | 1 | $670.72 | M T MADON EXPORTS | Tablet |
| 24 | 2MG INC | Philippines | 10 | $583.59 | BETA DRUGS LTD | Tablet |
| 25 | SANDOZ CANADA INC | Canada | 1 | $504.48 | SANDOZ PVT LTD | Tablet |
| 26 | CLYZ PHARMA SARL | Cameroon | 1 | $489.57 | RUN MEDWAY | Tablet |
| 27 | ABU AHMED | Kenya | 1 | $248.53 | AMARI TRADE ALLIANCE… | Tablet |
| 28 | GULF IMPEX FZC | Afghanistan | 1 | $153.08 | MEDMATRIX ASSOCIATES | Tablet |
| 29 | WELLPOINT MEDICAL & ONCOLOGY CENTER | Saint Kitts and Nevis | 1 | $71.44 | SPR ONCOCARE PVT LTD | Tablet |
| 30 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | 1 | $58.09 | J.A. UNITED EXPORTS … | Tablet |
| 31 | BISTRA PHARMA LINK PVT LTD | Nepal | 2 | $40.29 | KHANDELWAL LABORATOR… | Tablet |
| 32 | STATE TRADING ORGANIZATION PLC | Maldives | 1 | $21.63 | MC PHARMA DISTRIBUTORS | Tablet |
| 33 | THE MANAGER SA | Ghana | 1 | $4.70 | GRAMEEN PHARMA LLP | Tablet |
| 34 | GENERICS & SPECIALITIES LTD | Tanzania | 1 | $4.41 | EUGIA PHARMA SPECIAL… | Tablet |
| 35 | EMIRATES POST GROUP | United Arab Emirates | 2 | $0.218 | MOVID IMPEX | Tablet |
| 36 | LIFELINE PHARMACEUTICALS OF | Lesotho | 1 | $0.0000 | NUMED PHARMA DISTRIB… | Capsule |
This report covers 184 2025-Q4 Capecitabine shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/capecitabine
Talk to our trade analyst
Need a custom capecitabine report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/capecitabine
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Capecitabine product page
Live data, supplier directory, price trends, and trade route analysis